We are live on ! Find out more
ACM

ACT Capital Management Portfolio holdings

AUM $153M
This Fund
S&P 500
This Quarter Est. Return
-12.64%
1 Year Est. Return
–
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$94.5M
AUM Growth
-$43.8M
Cap. Flow
-$15M
Cap. Flow %
-15.87%
Top 10 Hldgs %
63.27%
Holding
99
New
7
Increased
9
Reduced
24
Closed
13

Top Buys

Rank Stock Value
1
NVDA icon
NVIDIA
NVDA
+$3.89M
2
DVN icon
Devon Energy
DVN
+$2.41M
3
QTEK
QualTek Services Inc. Class A Common Stock
QTEK
+$2.23M
4
LNTH icon
Lantheus
LNTH
+$1.5M
5
DOCN icon
DigitalOcean
DOCN
+$1.2M

Top Sells

Rank Stock Value
1
ARCT icon
Arcturus Therapeutics
ARCT
+$5.77M
2
UTHR icon
United Therapeutics
UTHR
+$2.92M
3
META icon
Meta Platforms (Facebook)
META
+$2.52M
4
VIR icon
Vir Biotechnology
VIR
+$2.43M
5
AUPH icon
Aurinia Pharmaceuticals
AUPH
+$1.87M

Sector Composition

Rank Sector Weight
1 Healthcare 75.56%
2 Technology 13.28%
3 Energy 4.44%
4 Financials 2.35%
5 Communication Services 1.63%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
BLRX
76
BioLineRX
BLRX
$11.8M
$47K 0.05%
688
– –
APLT
77
DELISTED
Applied Therapeutics
APLT
$42K 0.04%
20,000
– –
SYRS
78
DELISTED
Syros Pharmaceuticals, Inc. Common Stock
SYRS
$42K 0.04%
3,500
+1,350
+63% +$24.1K
ARAV
79
DELISTED
Aravive, Inc. Common Stock
ARAV
$34K 0.04%
17,500
+7,500
+75% +$16.1K
ATNM icon
80
Actinium Pharmaceuticals
ATNM
$23.5M
$33K 0.03%
6,500
-31,000
-83% -$163K
NKTR icon
81
Nektar Therapeutics
NKTR
$2.47B
$32K 0.03%
400
-2,667
-87% -$395K
GTH
82
DELISTED
Genetron Holdings Limited ADS
GTH
$16K 0.02%
2,500
– –
ABNB icon
83
Airbnb
ABNB
$90.5B
$9K 0.01%
50
– –
AVGR
84
DELISTED
Avinger, Inc. Common Stock
AVGR
$6K 0.01%
117
– –
GNCA
85
DELISTED
Genocea Biosciences, Inc.
GNCA
$6K 0.01%
5,000
– –
APVO icon
86
Aptevo Therapeutics
APVO
$5.22M
– –
0
– -$12K
AVXL icon
87
Anavex Life Sciences
AVXL
$297M
– –
-33,500
Closed -$581K
CCJ icon
88
Cameco
CCJ
$41.1B
– –
-12,000
Closed -$262K
CTRA
89
DELISTED
Coterra Energy
CTRA
– –
-30,000
Closed -$570K
FANG icon
90
Diamondback Energy
FANG
$52.4B
– –
-4,500
Closed -$485K
GDRX icon
91
GoodRx Holdings
GDRX
$1.11B
– –
-40,000
Closed -$1.31M
HLMN icon
92
Hillman Solutions
HLMN
$1.81B
– –
-65,000
Closed -$699K
META icon
93
Meta Platforms (Facebook)
META
$1.5T
– –
-7,500
Closed -$2.52M
ONON icon
94
On Holding
ONON
$12.7B
– –
-10,500
Closed -$397K
PUBM icon
95
PubMatic
PUBM
$627M
– –
-45,000
Closed -$1.53M
TGTX icon
96
TG Therapeutics
TGTX
$7.64B
– –
-33,900
Closed -$644K
TMDX icon
97
Transmedics
TMDX
$2.64B
– –
-1,000
Closed -$19K
UTHR icon
98
United Therapeutics
UTHR
$22B
– –
-13,500
Closed -$2.92M
VIR icon
99
Vir Biotechnology
VIR
$1.54B
– –
-58,000
Closed -$2.43M
1 2 3
4

Similar funds

BCI
Blue Capital Inc Omaha, Nebraska $153M AUM 28.69% 1-Year Est. Return
APW
Atlantic Private Wealth Chapel Hill, North Carolina $153M AUM 15.75% 1-Year Est. Return
DAM
Doheny Asset Management Los Angeles, California $153M AUM 42.04% 1-Year Est. Return
BVC
Bright Valley Capital Hong Kong $153M AUM 16.24% 1-Year Est. Return
RHAM
Round Hill Asset Management Pasadena, California $153M AUM 6.67% 1-Year Est. Return
RFN
Redwood Financial Network Solon, Ohio $153M AUM 17.17% 1-Year Est. Return
SGM
Sellaronda Global Management New York $152M AUM 2.1% 1-Year Est. Return
HWM
Horizons Wealth Management Asheville, North Carolina $152M AUM 9.43% 1-Year Est. Return

ACT Capital Management's Q1 2022 Portfolio in Review

As of Q1 2022, ACT Capital Management held 99 positions worth $94.5M, down 32% from $138M the previous quarter. Its ten largest holdings account for 63% of the portfolio.

ACT Capital Management withdrew a net $15M in Q1 2022, closing 13 positions and reducing 24 holdings. Its most notable exit was United Therapeutics, an estimated $2.92M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 76% of assets, down from 82% a quarter earlier, followed by Technology and Energy.

Against the trend, ACT Capital Management opened a new position in NVIDIA worth $4.23M.

  • ACT Capital Management's largest Q1 2022 buy was NVIDIA: 155,000 shares worth $4.23M.
  • ACT Capital Management added most to DigitalOcean in Q1 2022, an estimated $1.2M increase.
  • ACT Capital Management's biggest Q1 2022 reduction was Arcturus Therapeutics, cutting an estimated $5.77M.
  • ACT Capital Management fully exited United Therapeutics in Q1 2022, selling an estimated $2.92M.
  • ACT Capital Management's ten largest holdings make up 63% of its $94.5M portfolio in Q1 2022.
  • ACT Capital Management opened 7 new positions and closed 13 in Q1 2022.
  • ACT Capital Management's portfolio value fell 32% quarter-over-quarter to $94.5M.

Based on ACT Capital Management's 13F filing for Q1 2022, filed 11 May 2022.